Repository logo
 

Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication

Accepted version
Peer-reviewed

Type

Article

Change log

Authors

Farquhar, MJ 
Humphreys, IS 
Rudge, SA 
Wilson, GK 
Bhattacharya, B 

Abstract

Background & Aims

Chronic hepatitis C is a global health problem with an estimated 170 million hepatitis C virus (HCV) infected individuals at risk of progressive liver disease and hepatocellular carcinoma (HCC). Autotaxin (ATX, gene name: ENPP2) is a phospholipase with diverse roles in the physiological and pathological processes including inflammation and oncogenesis. Clinical studies have reported increased ATX expression in chronic hepatitis C, however, the pathways regulating ATX and its role in the viral life cycle are not well understood.

Methods

In vitro hepatocyte and ex vivo liver culture systems along with chimeric humanized liver mice and HCC tissue enabled us to assess the interplay between ATX and the HCV life cycle.

Results

HCV infection increased hepatocellular ATX RNA and protein expression. HCV infection stabilizes hypoxia inducible factors (HIFs) and we investigated a role for these transcription factors to regulate ATX. In vitro studies show that low oxygen increases hepatocellular ATX expression and transcriptome analysis showed a positive correlation between ATX mRNA levels and hypoxia gene score in HCC tumour tissue associated with HCV and other aetiologies. Importantly, inhibiting ATX-lysophosphatidic acid (LPA) signalling reduced HCV replication, demonstrating a positive role for this phospholipase in the viral life cycle. LPA activates phosphoinositide-3-kinase that stabilizes HIF-1α and inhibiting the HIF signalling pathway abrogates the pro-viral activity of LPA.

Conclusions

Our data support a model where HCV infection increases ATX expression which supports viral replication and HCC progression.

Lay summary

Chronic hepatitis C is a global health problem with infected individuals at risk of developing liver disease that can progress to hepatocellular carcinoma. Autotaxin generates the biologically active lipid lysophosphatidic acid that has been reported to play a tumorigenic role in a wide number of cancers. In this study we show that hepatitis C virus infection increases autotaxin expression via hypoxia inducible transcription factor and provides an environment in the liver that promotes fibrosis and liver injury. Importantly, we show a new role for lysophosphatidic acid in positively regulating hepatitis C virus replication.

Description

Keywords

autotaxin, hepatitis C virus, hypoxia, Hypoxia-Inducible Factor 1, alpha subunit, lipid signalling, lysophosphatidic acid

Journal Title

Journal of Hepatology

Conference Name

Journal ISSN

0168-8278
1600-0641

Volume Title

66

Publisher

Elsevier
Sponsorship
Research in the McKeating laboratory was funded by the MRC, NIHR Birmingham Liver BRU, EU FP7 PathCO and H2020 grant Hep-CAR. Research in the Wakelam lab is supported by BBSRC and Hep-CAR. Stephanie Roessler was supported by Hep-CAR, DFG grant RO4673, the Olympia-Morata Programme, a Brigitte-Schieben-Lange Fellowship and a Heidelberg School of Oncology Fellowship.